Does anyone have a successful strategy they could share for a biotech stock that is about to release phase 3 results. Given the boom or bust nature of biotech, I’m pretty much planning to sell the news and cover and let the rest ride out whatever happens.
Is there anything else to look out for? Length of time for acquisitions, etc? TIA
Leave a Reply